Does CANNABIDIOL Cause Product dose omission issue? 895 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 895 reports of Product dose omission issue have been filed in association with CANNABIDIOL (Epidiolex). This represents 4.9% of all adverse event reports for CANNABIDIOL.
895
Reports of Product dose omission issue with CANNABIDIOL
4.9%
of all CANNABIDIOL reports
10
Deaths
213
Hospitalizations
How Dangerous Is Product dose omission issue From CANNABIDIOL?
Of the 895 reports, 10 (1.1%) resulted in death, 213 (23.8%) required hospitalization, and 5 (0.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANNABIDIOL. However, 895 reports have been filed with the FAERS database.
What Other Side Effects Does CANNABIDIOL Cause?
Seizure (4,980)
Hospitalisation (1,840)
Off label use (1,636)
Product use in unapproved indication (1,585)
Diarrhoea (1,356)
Death (1,115)
Somnolence (1,005)
Drug ineffective (859)
Fatigue (715)
Weight increased (663)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CANNABIDIOL Alternatives Have Lower Product dose omission issue Risk?
CANNABIDIOL vs CANNABIDIOL\HERBALS
CANNABIDIOL vs CANNABIS SATIVA FLOWERING TOP
CANNABIDIOL vs CANNABIS SATIVA SUBSP. INDICA TOP
CANNABIDIOL vs CANRENOATE
CANNABIDIOL vs CANRENOIC ACID